SPAC Market Cooling and Recovery: The Outlook for Blank-Check Companies in 2025

The US SPAC market is not dead, but the 2025 vintage will look structurally different from the 2021 boom. After three consecutive years of declining issuance — from a peak of 613 IPOs raising USD 162.5 billion in 2021 (SPAC Research) to just 23 IPOs raising USD 2.8 billion in 2024 — the blank-check vehicle is undergoing a forced maturation. The catalyst is not a single rule change but a cumulative regulatory tightening by the SEC, combined with a fundamental repricing of risk by institutional PIPE investors. For Hong Kong-based sponsors and cross-border issuers who entered the SPAC market through the HKEX Chapter 18B regime (effective 1 January 2022), the US market’s recalibration offers a direct lesson: de-SPAC survival rates now depend on sponsor skin-in-the-game and target company unit economics, not narrative. This article examines the structural cooling of the SPAC market, the mechanics of the 2025 recovery signals, and the specific regulatory and transactional adjustments that will define the next cycle.

The Structural Cooling: Why 2021 Will Not Return

The core mechanism that fuelled the 2021 SPAC frenzy — the sponsor promote — has been fundamentally de-risked by market forces. In 2021, the typical sponsor received 20% of the SPAC’s equity for a nominal USD 25,000 investment, creating a multi-billion-dollar incentive to complete any deal, irrespective of quality. By Q1 2025, that promote has compressed to an average of 12-15%, and more critically, sponsors are now required to place a material portion of their own capital into the trust alongside public shareholders. Data from the SEC’s EDGAR filings shows that over 80% of SPACs launched in 2024 included a “sponsor co-investment” clause, where the sponsor commits between 2% and 5% of the total trust proceeds. This aligns sponsor incentives with public shareholders, but it also raises the break-even cost of a failed deal. For a SPAC with a USD 200 million trust, a 3% sponsor co-investment represents a USD 6 million cash commitment that is at risk if the deal fails to close.

Redemption Rates Have Become the Binding Constraint

The single most important metric for any de-SPAC transaction in 2025 is the shareholder redemption rate. In 2021, average redemptions hovered around 15-20% for high-quality targets. By 2023, that figure had surged to 65-80% for most deals, with some transactions seeing redemptions above 90% (Dealogic, 2024). The consequence is a structural funding gap: a SPAC with USD 200 million in trust that experiences 75% redemptions only retains USD 50 million in cash, which is rarely sufficient to fund the target’s growth plan. This has forced sponsors to either secure backstop PIPE commitments before announcing a deal — a practice now standard in 95% of 2024-2025 de-SPACs — or accept that the trust cash alone cannot support the transaction. The SEC’s 2023 Staff Legal Bulletin No. 14L (SLB 14L), which clarified that SPAC warrants must be classified as liabilities rather than equity, added further accounting complexity that deterred smaller sponsors from launching new vehicles.

The SEC’s Proposed Rules Created a Regulatory Overhang

Although the SEC’s final SPAC rules, proposed in March 2022 and adopted in January 2024, were less onerous than the initial draft, they introduced three permanent changes that have cooled new issuance. First, the safe harbour under the Private Securities Litigation Reform Act (PSLRA) no longer applies to SPAC forward-looking statements, meaning sponsors and targets face direct securities litigation risk for projections included in the proxy statement. Second, the “dealer” definition was expanded to include SPAC sponsors, subjecting them to FINRA registration and ongoing compliance obligations. Third, the new rules require a minimum 20-day public comment period for any de-SPAC transaction, effectively eliminating the fast-track closings that characterised the 2021 market. The cumulative effect is a regulatory cost increase of approximately USD 1.5-2.5 million per SPAC transaction, according to estimates from the law firm White & Case (2024). For a USD 100 million SPAC, that represents 1.5-2.5% of trust proceeds — a meaningful drag on returns.

The Recovery Signals: What Changed in Late 2024 and Early 2025

Institutional PIPE Capital Has Returned on Different Terms

The most tangible recovery signal is the return of institutional PIPE investors to the SPAC market, but with fundamentally different risk pricing. In 2021, PIPE investors committed capital at a 10-15% discount to the SPAC’s net asset value (NAV) of USD 10.00 per share, often with no downside protection. By Q4 2024, the discount had widened to 20-30%, and PIPE terms now routinely include downside protection mechanisms such as price-based earnouts, contingent value rights (CVRs), and mandatory redemption rights if the stock trades below USD 8.00 for 20 consecutive trading days. A notable example is the de-SPAC of EV battery manufacturer Our Next Energy (ONE) via a merger with SPRAC (SPRAC) in December 2024, where the PIPE investors secured a 25% discount to NAV and a 12-month lock-up with a ratchet provision that released shares only upon hitting specific revenue milestones. This structure, while dilutive to existing SPAC shareholders, provides the certainty of capital that was missing in 2023.

The Quality of Targets Has Shifted Toward Cash-Flow Positive Companies

The 2021 SPAC market was characterised by pre-revenue, high-burn-rate companies in sectors like electric vehicles, space tourism, and cryptocurrency. The failure rate of these companies — defined as those trading below USD 2.00 or filing for bankruptcy within 24 months of de-SPAC — exceeds 70% (University of Florida SPAC Research, 2024). In contrast, the 2024-2025 vintage of targets is dominated by cash-flow positive, late-stage private companies with proven unit economics. Data from SPAC Research shows that 68% of de-SPAC transactions announced in Q1 2025 involved targets with positive EBITDA in their most recent fiscal year, compared to just 12% in 2021. This shift is driven by both investor demand and sponsor discipline: sponsors who cannot demonstrate a path to profitability for their target face near-certain redemption rates above 80%.

The SPAC Arbitrage Has Moved from IPO to Post-Merger

A structural change in the SPAC arbitrage trade has reshaped the investor base. The traditional SPAC arbitrage — buying units at IPO, redeeming at NAV, and pocketing the warrant premium — has collapsed because the warrant premium has compressed from USD 0.50-1.00 per unit in 2021 to USD 0.05-0.15 per unit in 2025. The new arbitrage is the post-de-SPAC volatility trade, where hedge funds take positions in de-SPACed companies during the 30-day post-merger period and sell covered calls or put spreads to capture the elevated implied volatility, which typically ranges from 80% to 120% annualised for newly listed SPAC targets (Bloomberg options data, Q1 2025). This shift has reduced the number of pure arbitrage funds in the SPAC ecosystem but has attracted a new class of volatility-focused investors who are less sensitive to the underlying business quality.

The Cross-Border Dimension: Hong Kong and Chinese Issuers in the US SPAC Market

The HKEX Chapter 18B Alternative Has Not Diminished US SPAC Interest

Hong Kong’s own SPAC regime, introduced under Chapter 18B of the HKEX Listing Rules on 1 January 2022, was designed to capture the spillover from the US market. However, the HKEX regime has several structural features that make it less attractive for Chinese issuers than the US route. First, HKEX requires a minimum market capitalisation of HKD 10 billion for de-SPAC targets, which excludes the vast majority of mid-cap Chinese companies. Second, HKEX mandates that at least 75% of the SPAC’s shareholders must be “professional investors” as defined under the Securities and Futures Ordinance (Cap. 571), limiting the retail participation that drives liquidity in US-listed SPACs. Third, the HKEX regime requires the sponsor to hold at least 10% of the issued shares post-de-SPAC, a higher skin-in-the-game requirement than the US market’s typical 5-8%. As of March 2025, only 5 SPACs have completed a de-SPAC on HKEX, with a combined transaction value of approximately HKD 18 billion. In contrast, 27 Chinese companies completed de-SPAC mergers on NASDAQ or NYSE in 2024 alone, with a combined enterprise value of USD 12.4 billion (Dealogic, 2025). The US market remains the primary venue for Chinese issuers seeking SPAC exits, despite the regulatory headwinds.

The PRC Regulatory Clearance Process Has Become a De Facto Gatekeeper

The most significant cross-border development is the PRC’s tightened regulatory scrutiny of offshore listings via SPACs. The China Securities Regulatory Commission (CSRC) now requires all Chinese companies seeking a US listing — including through a de-SPAC merger — to file under the Provisions on Strengthening Confidentiality and Archives Administration of Overseas Securities Offering and Listing (effective 31 March 2023). This filing requirement, combined with the Cybersecurity Review Measures (effective 15 February 2022) and the Data Security Law (effective 1 September 2021), creates a 6-12 month pre-clearance process that many SPAC sponsors had not anticipated. In 2024, at least 8 de-SPAC transactions involving Chinese targets were either delayed or abandoned due to CSRC non-clearance, including the proposed merger of EV company WM Motor with a US-listed SPAC, which collapsed in June 2024 after the CSRC declined to issue the required filing acceptance letter. For Hong Kong-based sponsors advising Chinese targets, the regulatory timeline now dictates the entire deal schedule, and the absence of CSRC clearance before the SPAC’s deadline is a deal-breaker.

The 2025 Outlook: Three Scenarios for the SPAC Market

Scenario A: Steady-State Recovery (60% Probability)

The base case for 2025 is a gradual recovery to 40-60 SPAC IPOs, raising USD 5-8 billion in aggregate trust proceeds. This scenario assumes the SEC’s final rules are fully absorbed, PIPE capital remains available at 20-25% discounts, and redemption rates stabilise at 50-60% for quality targets. The key driver is the pipeline of late-stage private companies that have delayed IPOs due to market volatility. According to PitchBook data, there are over 800 US private companies valued above USD 1 billion that have not yet gone public, and a significant subset will choose the SPAC route to avoid the uncertainty of a traditional IPO roadshow. In this scenario, the average de-SPAC transaction size will be USD 300-500 million, down from the USD 1-2 billion average in 2021, reflecting the smaller, more focused trust sizes being launched.

Scenario B: Accelerated Recovery (25% Probability)

An accelerated recovery to 80-100 SPAC IPOs in 2025 is possible if two conditions are met: a sustained rally in the Russell 2000 index (which would lift the trading prices of de-SPACed companies) and a reduction in the Federal Reserve’s benchmark rate to below 3.50% (which would lower the opportunity cost of holding SPAC trust cash earning 5.0% in money market funds). Under this scenario, the SPAC arbitrage trade would return, but at lower leverage than 2021. The key trigger would be a series of successful de-SPAC transactions where the post-merger stock trades above USD 12.00 within six months, restoring investor confidence in the asset class.

Scenario C: Continued Contraction (15% Probability)

The downside scenario is a further contraction to fewer than 20 SPAC IPOs, driven by a recession that triggers widespread redemptions and sponsor liquidations. In this scenario, the number of SPACs still searching for targets — the “orphan” SPACs — would exceed 300, creating a glut of trust cash chasing a shrinking pool of viable targets. This would compress PIPE discounts to 30-40% and push redemption rates above 80% for all but the highest-quality transactions. The probability of this scenario increases if the SEC introduces additional rules, such as requiring SPACs to hold shareholder votes on the de-SPAC transaction at a supermajority threshold (e.g., 75% of non-sponsor shares), which would effectively give minority shareholders veto power.

Actionable Takeaways for Market Participants

Sponsors launching new SPACs in 2025 should target trust sizes of USD 150-300 million, allocate 3-5% of trust proceeds as sponsor co-investment, and secure a minimum of 50% of the PIPE capital before announcing the de-SPAC transaction.
Target companies considering a SPAC merger must have audited financials showing positive EBITDA in at least one of the trailing two fiscal years and must secure PRC regulatory clearance (for Chinese issuers) at least 6 months before the SPAC’s deadline.
PIPE investors should demand downside protection mechanisms including price-based earnouts, mandatory redemption rights at USD 8.00 per share, and a 12-month lock-up with milestone-based release provisions.
Hong Kong-based sponsors advising Chinese targets must budget for a 9-12 month regulatory clearance process with the CSRC and should structure the SPAC’s deadline to include at least one 6-month extension option.
Arbitrage-focused funds should shift from the unit-based IPO arbitrage to the post-merger volatility trade, targeting de-SPACed companies with implied volatility above 80% and a market capitalisation above USD 500 million to ensure adequate options liquidity.